Skip to main content

Day: April 6, 2020

Euro Manganese Announces Closing of First Tranche of Private Placement and Grant of Stock Options

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, April 06, 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V / ASX: EMN) (the “Company” or “EMN“) is pleased to announce the closing of the first tranche of the non-brokered private placement (the “Offering“) announced on March 24, 2020, and a grant of stock options. Closing of First Tranche of Private PlacementThe first tranche was comprised of 4,477,170 common shares (“Shares“) and 227,273 CHESS Depositary Interests (“CDIs“, with each CDI representing one Share), at a price of C$0.11 per Share and A$0.13 per CDI, respectively, for aggregate gross proceeds of C$517,489.The second tranche of the Offering (the “Related Parties Tranche“),...

Continue reading

CRAWFORD & COMPANY PROVIDES BUSINESS UPDATE

ATLANTA, April 06, 2020 (GLOBE NEWSWIRE) — Crawford & Company (www.crawco.com) (NYSE: CRD-A and CRD-B), the world’s largest publicly listed independent provider of claims management and outsourcing solutions to insurance companies and self-insured entities, today announced a business update in response to COVID-19 and its ongoing impact on the global economy.In light of the rapidly evolving nature of the novel COVID-19 pandemic, Crawford & Company withdraws its 2020 guidance provided on the Company’s fourth quarter and full year 2019 earnings call on March 5, 2020. Crawford & Company will provide additional business updates during its first quarter 2020 earnings call.“Crawford is closely monitoring the unprecedented COVID-19 situation and its financial impact on our business operations. At this time, the health and...

Continue reading

Crinetics Pharmaceuticals Reports Positive Interim Results for the ACROBAT Edge Phase 2 Trial of Paltusotine (CRN00808) in Acromegaly Patients and Provides Corporate Update

Data from initial patients who have completed the ongoing open label Edge trial show that IGF-1 levels were maintained after 13 weeks of treatment when patients were switched to once daily oral paltusotine from commercially available depot injections of the peptide somatostatin receptor ligands, octreotide or lanreotide.ACROBAT Edge recruitment is complete and topline data from all patients in the trial is expected in the fourth quarter of 2020Crinetics plans to advance paltusotine into Phase 3 for patients with acromegaly in the first half of 2021 with to-be-marketed formulation and also into Phase 2 for patients with neuroendocrine tumors who suffer from carcinoid syndromeManagement to host webcast/conference call Tuesday, April 7, 2020 at 8 a.m. EDT / 5 a.m. PDTSAN DIEGO, April 06, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals,...

Continue reading

Sunrun Provides Update on First Quarter 2020

First Quarter Performance of 97.4 Megawatts Deployed, $366 Million in Total Cash BalanceAccelerating Transition to a Digital Sales and Streamlined Operating Model to Provide Essential Service, Reducing Soft CostsProject Finance Runway Extended, At Materially Identical TermsSAN FRANCISCO, April 06, 2020 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), the nation’s leading provider of residential solar, storage and energy services, today announced select, preliminary and unaudited financial and operational performance metrics for the first quarter of 2020.Preliminary Unaudited First Quarter PerformanceIn the first quarter of 2020, Megawatts Deployed was 97.4. The company ended the quarter with $366 million in total cash, an increase of $3 million from the fourth quarter, including $286 million in unrestricted cash, an increase of $17 million...

Continue reading

Brookfield Renewable Partners 2020 First Quarter Conference Call and Webcast for Investors and Analysts

Date: Wednesday, May 6, 2020Time: 9:00 a.m. (Eastern Time)BROOKFIELD, News, April 06, 2020 (GLOBE NEWSWIRE) — You are invited to participate in Brookfield Renewable Partners’ (TSX: BEP.UN; NYSE: BEP) 2020 First Quarter Conference Call and Webcast on Wednesday, May 6, 2020 at 9:00 a.m. (Eastern Time) to discuss results and current business initiatives with members of senior management.These results will be released on Wednesday, May 6, 2020 at approximately 7:00 a.m. and will be available on our website at http://bep.brookfield.com under “Press Releases”. To participate in the conference call, please dial 1-866-688-9430 toll-free at approximately 8:50 a.m. If calling from outside Canada or the U.S., dial 1-409-216-0817. When prompted, enter the conference ID, 9254309. The conference call will also be webcast live at https://edge.media-server.com/mmc/p/z8d43nof,...

Continue reading

Sprout Social to Announce First Quarter 2020 Financial Results on May 6, 2020

CHICAGO, April 06, 2020 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social” or the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the first quarter ended March 31, 2020 after market close on Wednesday, May 6, 2020.The financial results and business highlights will be discussed on a conference call and webcast scheduled at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) on Wednesday, May 6, 2020. The conference call can be accessed by dialing (877) 658-9099 from the United States and Canada or (602) 563-8734 internationally with conference ID 1086133. The live webcast of the conference call can be accessed from Sprout Social’s investor relations website at http://investors.sproutsocial.com.Following the completion...

Continue reading

CNH Industrial confirms Annual General Meeting and removes dividend proposal

London, April 6, 2020CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) confirms that its Annual General Meeting of shareholders (“AGM”) will be held on April 16, 2020 in Amsterdam, The Netherlands, as previously announced. Due to travel bans and local restrictions on meetings issued because of the COVID-19 outbreak, it is anticipated that executive and non-executive directors will attend our AGM via remote connection. Furthermore, for health and safety reasons, the Company will take appropriate measures to minimize public health risks relating to the AGM and further measures will be introduced in the event local prescriptions will be amended. CNH Industrial therefore reserves the right to amend the physical arrangements on the day of the AGM, including refusing entry to the meeting to comply with health and safety requirements.As a result of...

Continue reading

CNH Industrial conferma l’Assemblea degli Azionisti e ritira la proposta relativa alla distribuzione del dividendo

Londra, 6 aprile 2020CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) conferma che la propria Assemblea degli Azionisti sarà tenuta il 16 aprile 2020 ad Amsterdam, nei Paesi Bassi, come precedentemente annunciato. A causa delle limitazioni ai viaggi e delle locali restrizioni relative alla possibilità di radunarsi in seguito alla diffusione del COVID-19, è previsto che gli Amministratori esecutivi e non esecutivi partecipino all’Assemblea da remoto. Inoltre, per ragioni di salute e sicurezza, la Società predisporrà adeguate misure per minimizzare eventuali rischi alla salute pubblica legati all’Assemblea e ulteriori misure saranno introdotte nel caso le prescrizioni locali vengano aggiornate. CNH Industrial pertanto si riserva il diritto di modificare le disposizioni pratiche il giorno stesso dell’Assemblea, inclusa la possibilità di rifiutare...

Continue reading

LINCOLN ELECTRIC SCHEDULES WEBCAST FOR FIRST QUARTER 2020 RESULTS

CLEVELAND, April 06, 2020 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its first quarter 2020 results on Monday, April 27, 2020 prior to market open.  An investor webcast will take place at 10:00 a.m. (ET) later that day. The earnings call will be webcast live in listen-only mode on the Company’s Investor Relations web site at https://ir.lincolnelectric.com.  Listeners should go to the web site prior to the call to register, download and install any necessary audio software. If investors would like to ask questions, please dial (877) 344-3899 (domestic) or (315) 625-3087 (international) and use confirmation code 9746539. Telephone participants are asked to dial in 10 to 15 minutes prior to the start of the conference call. A replay of the earnings call...

Continue reading

Natus Announces Preliminary First Quarter Revenue

PLEASANTON, Calif., April 06, 2020 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced its first quarter revenue estimate and withdrew its full year 2020 guidance.For the first quarter 2020, the Company expects to report revenue between $109 million and $110 million compared to its previous guidance of $113 million and $117 million.  The Company will report its first quarter financial results after the close of the market on Thursday, April 30th.“As the first quarter ended, it became apparent that the effects of the COVID-19 virus were more global and wide spread than we expected in our February 6th guidance,” said Jonathan...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.